Literature DB >> 26770455

Downregulation of cell cycle-related proteins in ovarian cancer line and cell cycle arrest induced by microRNA.

Jian-Mei Yuan1, Xue-Jun Shi1, Ping Sun2, Jun-Xia Liu1, Wei Wang1, Ming Li1, Feng-Yu Ling1.   

Abstract

OBJECTIVE: The effect of miR-449 and miR-34 on the growth, cell cycle and target gene expressions of ovarian cancer cell line SKOV3 and SKOV3-ipl was discussed.
METHOD: Real-time quantitative reverse transcription PCR was employed to detect the expressions of miR-449a/b and miR-34b, c in SKOV3 and SKOV3-ipl cells. The two miRNAs were successfully expressed in SKOV3-ipl cells by transfection. The variations in cell growth rate and cell cycle were determined by MTS assay and flow cytometry, respectively. The expressions of cell cycle-related proteins were detected by Western Blot.
RESULTS: miR-449b and miR-34c induced the decline of the adhesiveness of SKOV3-ipl cells by 20%-30%. The number of cells arrested in G1-phase increased and the number of cells arrested in S-phase decreased significantly. The cell cycle-related proteins CDK6 and CDC254 were downregulated. miR-449b caused the expression of CDK6 and CDC25A to decrease. After the co-transfection with miR-449b and miR-34c, the relevant proteins were downregulated more significantly. The expressions of CDK6, CDC25A and cyclin A were decreased significantly.
CONCLUSION: miR-449b and miR-34c can induce cell cycle arrest in SKOV3-ipl cells and the downregulation of CDK6, CDC25A and cyclin A.

Entities:  

Keywords:  Ovarian tumor; cell cycle-related proteins; microRNAs

Year:  2015        PMID: 26770455      PMCID: PMC4694355     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Aloperine induces G2/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells.

Authors:  Li Zhang; Yanxin Zheng; Hongzhu Deng; Lei Liang; Juan Peng
Journal:  Int J Mol Med       Date:  2014-03-31       Impact factor: 4.101

Review 2.  Mutant p53 reactivation by small molecules makes its way to the clinic.

Authors:  Vladimir J N Bykov; Klas G Wiman
Journal:  FEBS Lett       Date:  2014-04-24       Impact factor: 4.124

3.  Frequent downregulation of miR-34 family in human ovarian cancers.

Authors:  David C Corney; Chang-Il Hwang; Andres Matoso; Markus Vogt; Andrea Flesken-Nikitin; Andrew K Godwin; Aparna A Kamat; Anil K Sood; Lora H Ellenson; Heiko Hermeking; Alexander Yu Nikitin
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

4.  Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer.

Authors:  Britt K Erickson; Isaac Kinde; Zachary C Dobbin; Yuxuan Wang; Jovana Y Martin; Ronald D Alvarez; Michael G Conner; Warner K Huh; Richard B S Roden; Kenneth W Kinzler; Nickolas Papadopoulos; Bert Vogelstein; Luis A Diaz; Charles N Landen
Journal:  Obstet Gynecol       Date:  2014-11       Impact factor: 7.661

5.  Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.

Authors:  Markus Vogt; Johanna Munding; Martha Grüner; Sven-Thorsten Liffers; Berlinda Verdoodt; Jennifer Hauk; Lars Steinstraesser; Andrea Tannapfel; Heiko Hermeking
Journal:  Virchows Arch       Date:  2011-01-12       Impact factor: 4.064

Review 6.  The p53/miR-34 axis in development and disease.

Authors:  Matjaz Rokavec; Huihui Li; Longchang Jiang; Heiko Hermeking
Journal:  J Mol Cell Biol       Date:  2014-05-09       Impact factor: 6.216

7.  Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.

Authors:  Ernest Nadal; Guoan Chen; Marc Gallegos; Lin Lin; Daysha Ferrer-Torres; Anna Truini; Zhuwen Wang; Jules Lin; Rishindra M Reddy; Roger Llatjos; Ignacio Escobar; Juan Moya; Andrew C Chang; Felipe Cardenal; Gabriel Capellà; David G Beer
Journal:  Clin Cancer Res       Date:  2013-10-15       Impact factor: 12.531

8.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

Authors:  Nina Raver-Shapira; Efi Marciano; Eti Meiri; Yael Spector; Nitzan Rosenfeld; Neta Moskovits; Zvi Bentwich; Moshe Oren
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

9.  TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

Authors:  Pavla Brachova; Samuel R Mueting; Matthew J Carlson; Michael J Goodheart; Anna M Button; Sarah L Mott; Donghai Dai; Kristina W Thiel; Eric J Devor; Kimberly K Leslie
Journal:  Int J Oncol       Date:  2014-11-11       Impact factor: 5.650

10.  MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.

Authors:  Mingguang Lai; Gang Du; Ruiyue Shi; Jun Yao; Genhua Yang; Yue Wei; Dingguo Zhang; Zhenglei Xu; Ru Zhang; Yingxue Li; Zicheng Li; Lisheng Wang
Journal:  Mol Med Rep       Date:  2015-01-12       Impact factor: 2.952

View more
  6 in total

1.  Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.

Authors:  Yongxiao Li; Tao Jiang; Liwei Shao; Yan Liu; Chen Zheng; Yanfeng Zhong; Jing Zhang; Qing Chang
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

2.  Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6.

Authors:  Jian Cao; Yuan Zhang; Juan Mu; Dazhen Yang; Xiaoyan Gu; Jing Zhang
Journal:  Hum Cell       Date:  2021-04-03       Impact factor: 4.174

Review 3.  Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells.

Authors:  Hasan Onur Caglar; Cigir Biray Avci
Journal:  Mol Biol Rep       Date:  2020-02-28       Impact factor: 2.316

4.  Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.

Authors:  Sungshim L Park; Maarit I Tiirikainen; Yesha M Patel; Lynne R Wilkens; Daniel O Stram; Loic Le Marchand; Sharon E Murphy
Journal:  Carcinogenesis       Date:  2016-01-27       Impact factor: 4.944

5.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

Review 6.  Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas.

Authors:  Camille Jacques; Robel Tesfaye; Melanie Lavaud; Steven Georges; Marc Baud'huin; François Lamoureux; Benjamin Ory
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.